Form 10-K405/A - Annual report [Sections 13 and 15(d), S-K Item 405]: [Amend]
SEC Accession No. 0000912057-97-001049
Filing Date
1997-01-16
Accepted
1997-01-16 00:00:00
Documents
7
Period of Report
1996-09-30
SROs
AMEX

Document Format Files

Seq Description Document Type Size
1 10-K405/A 10-K405/A 95525
2 EX-10.16 EX-10.16 187336
3 EX-11.1 EX-11.1 2696
4 EX-13.1 EX-13.1 90708
5 EX-23.1 EX-23.1 916
6 FINANCIAL DATA SCHEDULE EX-27 2308
7 EX-99 EX-99 1994
  Complete submission text file 0000912057-97-001049.txt   383481
Mailing Address 4350 EXECUTIVE DR STE 310 SAN DIEGO CA 92121
Business Address 4350 EXECUTIVE DR STE 310 SAN DIEGO CA 92121 6194534040
MAXIM PHARMACEUTICALS INC (Filer) CIK: 0001013351 (see all company filings)

EIN.: 870279983 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K405/A | Act: NE | File No.: 001-14430 | Film No.: 97506681
SIC: 2833 Medicinal Chemicals & Botanical Products